Market For Gene Therapy and Antisense Drugs

Aug 1, 1995
217 Pages - Pub ID: KLI140270
Abstract Table of Contents Search Inside Report Related Reports
Now 50% off the original sale price of $3,250.
Once approved, gene therapy will completely supersede approaches to diseases that treat symptoms rather than affect a cure. The gene therapy market will grow quickly and is forecast to hit $3.2 billion in 2000 and $60 billion in 2005. This report from Kalorama Information examines the advantages and disadvantages of the various types of gene therapy and assesses which technologies and companies are likely to lead the market. Examines the most promising products and technologies, technological challenges, and possible solutions. Analyzes strategies used by the competitors involved in developing gene therapy and predicts which company is likely to be first to launch a product. Includes market forecasts for leading product sectors. Profiles AntiVirals, Avigen, Cell Genesys, Gene Medicine, Enzo Biochem, Genetic Therapy, and others.

Related Reports:

The Market for Wellness Programs and Their Impact on Pharmaceutical, Diagnostic and Device Product Markets
Oct 1, 2009 - KLI2384194 - $3,995.00

The Worldwide Market for Anti-Infectives (Antifungals, Antibacterials and Antivirals)
Oct 1, 2009 - KLI2435380 - $3,500.00

Rx to OTC Switches 2009
May 1, 2009 - KLI2196300 - $3,500.00

Stem Cell Therapeutics Markets
Feb 1, 2009 - KLI2021959 - $2,500.00

Women's Health: Worldwide Prescription Drug Markets
Feb 1, 2009 - KLI2071673 - $2,995.00

Pharmaceutical Outsourcing Post-Launch : Contract Manufacturing, Biomanufacturing and Sales, 3rd Edition
Jan 1, 2009 - KLI1646605 - $3,500.00

Pharmaceutical Markets in Brazil, Russia, India and China ( BRIC nations )
Jul 1, 2008 - KLI1614109 - $2,500.00

The Return of the Rx to OTC Switch: Market Analysis and Product Management Strategies
Apr 1, 2008 - KLI1692599 - $1,995.00

World Market for Prescription Generic Drugs, 6th Edition
Apr 1, 2008 - KLI1614095 - $3,995.00

Key Topics in Pharmaceutical Market Strategy 2008 (Drug Pricing, Rx to OTC switches, Retail Clinics, Prescribing Pharmacists, The Growing Out of Pocket Healthcare Market)
Mar 15, 2008 - KLI1689635 - $6,995.00

800.298.5603
Int'l: +1.240.747.3096
Questions?
Contact a research specialist >

Most Popular Research
Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development
DNA Sequencing Equipment and Services Markets, 2nd Edition
SNP Genotyping and Analysis Markets
Stem Cell Therapeutics Markets
Cell Culture: The World Market for Media, Sera and Reagents, 2nd Edition
Companion Diagnostics Markets (A Realistic Assessment of the Opportunities, Challenges, Key Players and Important Trends in 'Theranostics' and Personalized Medicine)
Privacy Policy    |    Terms and Conditions    |    Site Map    |    Return Policy    |    Press    |    Help FAQs
Copyright © 2010 Kalorama Information. All Rights Reserved.
A division of Market Research Group, LLC
Trust-e Logo
Contact Us: 800.298.5603 (U.S.)
or +1.240.747.3096 (Int'l)
Hours: Monday - Thursday: 3:00am - 7:00pm eastern time
Fridays: 3:00am - 6:00pm eastern time